International Stem Cell (ISCO) Short Interest Ratio & Short Volume → How a $0.25 cent option contract makes my top traders feel (From DTI) (Ad) Free ISCO Stock Alerts $0.06 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest International Stem Cell Short Interest DataCurrent Short Volume100 sharesPrevious Short Volume0 sharesChange Vs. Previous Month+∞Dollar Volume Sold Short$10.00Short Interest Ratio / Days to Cover0.0Last Record DateDecember 15, 2023Today's Trading Volume525 sharesAverage Trading Volume1,260 sharesToday's Volume Vs. Average42% Short Selling International Stem Cell ? Sign up to receive the latest short interest report for International Stem Cell and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatISCO Short Interest Over TimeISCO Days to Cover Over TimeISCO Percentage of Float Shorted Over Time Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details International Stem Cell Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/2023100 shares $10.00 No ChangeN/A0 $0.10 10/31/20231,300 shares $187.20 No ChangeN/A0.3 $0.14 8/15/2023800 shares $112.00 No ChangeN/A0.2 $0.14 3/31/2023100 shares $18.00 No ChangeN/A0 $0.18 10/31/2022500 shares $145.00 -78.3%N/A0.1 $0.29 10/15/20222,300 shares $726.57 No ChangeN/A3.8 $0.32 Get the Latest News and Ratings for ISCO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for International Stem Cell and its competitors with MarketBeat's FREE daily newsletter. 9/30/20222,300 shares $850.77 No ChangeN/A2.9 $0.37 8/31/20224,000 shares $1,560.00 +1,900.0%N/A0.7 $0.39 8/15/2022200 shares $66.00 No ChangeN/A0.1 $0.33 7/15/20221,500 shares $689.70 +275.0%N/A1.1 $0.46 6/30/2022400 shares $163.92 -50.0%N/A0.1 $0.41 6/15/2022800 shares $272.00 +166.7%N/A0.1 $0.34 5/31/2022300 shares $129.00 No ChangeN/A0 $0.43 4/15/2022300 shares $134.70 -25.0%N/A0.1 $0.45 3/31/2022400 shares $192.00 +100.0%N/A0 $0.48 3/15/2022200 shares $73.50 No ChangeN/A0 $0.37 1/15/2022100 shares $48.60 No ChangeN/A0 $0.49 12/31/2021100 shares $47.30 No ChangeN/A0 $0.47 11/30/20211,800 shares $900.00 -28.0%N/A0.2 $0.50 11/15/20212,500 shares $1,275.00 +2,400.0%N/A0.3 $0.51 10/29/2021100 shares $50.00 No ChangeN/A0 $0.50 10/15/2021100 shares $52.00 -80.0%N/A0 $0.52 9/30/2021500 shares $267.23 -16.7%N/A0 $0.53 9/15/2021600 shares $334.20 -40.0%N/A0.1 $0.56 8/31/20211,000 shares $620.00 +100.0%N/A0.1 $0.62 8/13/2021500 shares $275.00 No ChangeN/A0.1 $0.55 6/30/2021100 shares $67.11 -50.0%N/A0 $0.67 6/15/2021200 shares $70.00 -96.4%N/A0 $0.35 5/28/20215,600 shares $2,184.00 +5,500.0%N/A0.3 $0.39 5/14/2021100 shares $45.30 -80.0%N/A0 $0.45 4/30/2021500 shares $289.00 No ChangeN/A0 $0.58 3/15/2021100 shares $80.00 No ChangeN/A0 $0.80 2/26/2021100 shares $95.99 -97.5%N/A0 $0.96 2/12/20214,000 shares $3,720.00 +25.0%N/A0.2 $0.93 1/29/20213,200 shares $1,600.00 +357.1%N/A0.3 $0.50 12/31/2020400 shares $164.00 No ChangeN/A0 $0.41 11/30/20201,200 shares $600.00 -89.2%N/A0.2 $0.50 11/15/202011,100 shares $6,438.00 No ChangeN/A2 $0.58 9/30/2020300 shares $183.00 +50.0%N/A0.3 $0.61 9/15/2020200 shares $128.00 No ChangeN/A0.1 $0.64My top 100 stocks… (Ad)We recently ran an internal audit of every trade recommendation I’ve published across all my services… And let me tell ya, we found some incredible insights… For starters, we found about 100 stocks I trade really, really well.Get some cool freebies right here. ISCO Short Interest - Frequently Asked Questions What is International Stem Cell's current short interest? Short interest is the volume of International Stem Cell shares that have been sold short but have not yet been covered or closed out. As of December 15th, traders have sold 100 shares of ISCO short. Learn More on International Stem Cell's current short interest. Is International Stem Cell's short interest increasing or decreasing? International Stem Cell saw a increase in short interest during the month of December. As of December 15th, there was short interest totaling 100 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does International Stem Cell's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to International Stem Cell: Abliva AB (publ) (0.00%), American Bio Medica Co. (0.00%), Anthera Pharmaceuticals, Inc. (0.06%), Context Therapeutics Inc. (0.29%), Grifols, S.A. (2.57%), LAVA Therapeutics (1.37%), Mainz Biomed (2.30%), and Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($4.67 billion), General Motors ($4.33 billion), T-Mobile US, Inc. ($4.30 billion), Charter Communications, Inc. ($3.12 billion), Coinbase Global, Inc. ($3.12 billion), Occidental Petroleum Co. ($2.94 billion), Tractor Supply ($2.71 billion), Rivian Automotive, Inc. ($2.32 billion), United Rentals, Inc. ($2.22 billion), and Royal Caribbean Cruises Ltd. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short International Stem Cell stock? Short selling ISCO is an investing strategy that aims to generate trading profit from International Stem Cell as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against International Stem Cell? A short squeeze for International Stem Cell occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ISCO, which in turn drives the price of the stock up even further. How often is International Stem Cell's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ISCO, twice per month. The most recent reporting period available is December, 15 2023. More Short Interest Resources from MarketBeat Related Companies: Abliva AB (publ) Short Interest Data Affymax Short Interest Data American Bio Medica Short Interest Data Anthera Pharmaceuticals Short Interest Data Bayer Aktiengesellschaft Short Interest Data Context Therapeutics Short Interest Data EOM Pharmaceuticals Short Interest Data EPIRUS Biopharmaceuticals Short Interest Data Genmab A/S Short Interest Data GlobeImmune Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ISCO) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithProtect Your Bank Account Before It’s Too LateWeiss RatingsWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace